The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis

Adolph, 1987, Mapping of the oncogenes Myc, Sis, and int-1 to the distal part of mouse chromosome 15, Cytogenet. Cell Genet., 44, 65, 10.1159/000132345

Ahmad, 1998, Stromelysin 3, Am. J. Pathol., 152, 721

Alexander, 1996, Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene, J. Cell Biol., 135, 1669, 10.1083/jcb.135.6.1669

Bachman, 1999, Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggests a suppressor role in kidney, brain, and other human cancers, Cancer Res., 59, 798

Bain, 1997, E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas, Mol. Cell. Biol., 17, 4782, 10.1128/MCB.17.8.4782

Birchmeier, 1996, Epithelial-mesenchymal transitions in cancer progression, Acta Anat., 156, 217, 10.1159/000147848

Borsi, 1992, Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues, Int. J. Cancer, 52, 688, 10.1002/ijc.2910520504

Boudreau, 1995, Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix, Science, 267, 891, 10.1126/science.7531366

Chin, 1997, Matrix metalloproteinases regulate morphogenesis, migration and remodeling of epithelium, tongue skeletal muscle and cartilage in the mandibular arch, Development, 124, 1519, 10.1242/dev.124.8.1519

Christofori, 1999, The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene, Trends Biochem. Sci., 24, 73, 10.1016/S0968-0004(98)01343-7

Coussens, 1996, Matrix metalloproteinases and the development of cancer, Chem. Biol., 3, 895, 10.1016/S1074-5521(96)90178-7

D'Armiento, 1995, Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis, Mol. Cell. Biol., 15, 5732, 10.1128/MCB.15.10.5732

DeOme, 1959, Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice, Cancer Res., 19, 515

Domagala, 1990, Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction, Am. J. Pathol., 136, 219

Donehower, 1995, Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability, Genes Dev., 9, 882, 10.1101/gad.9.7.882

Emmert-Buck, 1996, Laser capture microdissection, Science, 274, 998, 10.1126/science.274.5289.998

Fisher, 1975, The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4), Cancer, 36, 1, 10.1002/1097-0142(197507)36:1<1::AID-CNCR2820360102>3.0.CO;2-4

Fowlkes, 1994, Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures, J. Biol. Chem., 269, 25742, 10.1016/S0021-9258(18)47310-3

Gack, 1994, Phenotypic alterations in fos-transgenic mice correlate with changes in Fos/Jun-dependent collagenase type I expression. Regulation of mouse metalloproteinases by carcinogens, tumor promoters, cAMP, and Fos oncoprotein, J. Biol. Chem., 269, 10363, 10.1016/S0021-9258(17)34069-3

Gilles, 1996, The epithelial to mesenchymal transition and metastatic progression in carcinoma, Breast J., 2, 83, 10.1111/j.1524-4741.1996.tb00076.x

Hay, 1995, An overview of epithelio-mesenchymal transformation, Acta Anat., 154, 8, 10.1159/000147748

Hirai, 1998, Epimorphin functions as a key morphoregulator for mammary epithelial cells, J. Cell Biol., 140, 159, 10.1083/jcb.140.1.159

Howe, 1998, Mutations in the SMAD4/DPC4 gene in juvenile polyposis, Science, 280, 1086, 10.1126/science.280.5366.1086

Hsieh, 1998, Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis, Cancer Res., 58, 3942

Jacobs, 1999, Radial scars in benign breast-biopsy specimens and the risk of breast cancer, N. Engl. J. Med., 340, 430, 10.1056/NEJM199902113400604

Jacoby, 1997, A juvenile polyposis tumor suppressor locus at 10q22 is deleted from nonepithelial cells in the lamina propria, Gastroenterology, 112, 1398, 10.1016/S0016-5085(97)70156-2

Kataoka, 1999, Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of α-proteinase inhibitor generated by matrix metalloproteinases, Am. J. Pathol., 154, 457, 10.1016/S0002-9440(10)65292-3

Kim, 1998, Tissue-specific expression of β-catenin in normal mesenchyme and uveal melanomas and its effect on invasiveness, Exp. Cell Res., 245, 79, 10.1006/excr.1998.4238

Levi, 1996, Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1, Proc. Natl. Acad. Sci. USA, 93, 7069, 10.1073/pnas.93.14.7069

Liu, 1998, Amplification of Ki-ras and elevation of MAP kinase activity during mammary tumor progression in C3(1)/SV40 Tag transgenic mice, Oncogene, 17, 2403, 10.1038/sj.onc.1202456

Lochter, 1997, Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells, J. Cell Biol., 139, 1861, 10.1083/jcb.139.7.1861

Lochter, 1999, α1 and α2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression, Mol. Biol. Cell, 10, 271, 10.1091/mbc.10.2.271

Lukashev, 1998, ECM signaling, Trends Cell Biol., 8, 437, 10.1016/S0962-8924(98)01362-2

Lund, 1996, Two distinct phases of apoptosis in mammary gland involution, Development, 122, 181, 10.1242/dev.122.1.181

Martorana, 1998, Epithelial cells up-regulate matrix metalloproteinases in cells within the same mammary carcinoma that have undergone an epithelial-mesenchymal transition, Cancer Res., 58, 4970

Masson, 1998, In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy, J. Cell Biol., 140, 1535, 10.1083/jcb.140.6.1535

Matrisian, 1985, Epidermal growth factor and oncogenes induce transcription of the same cellular mRNA in rat fibroblasts, EMBO J., 4, 1435, 10.1002/j.1460-2075.1985.tb03799.x

Mehindate, 1996, Interleukin-4, transforming growth factor beta 1, and dexamethasone inhibit superantigen-induced prostaglandin E2-dependent collagenase gene expression through their action on cyclooxygenase-2 and cytosolic phospholipase A2, Lab. Invest., 75, 529

Muller, 1988, The collagenase gene family in humans consists of at least four members, Biochem. J., 253, 187, 10.1042/bj2530187

Noe, 1999, Inhibition of adhesion and induction of epithelial invasion by HAV-containing E-cadherin-specific peptides, J. Cell Sci., 112, 127, 10.1242/jcs.112.1.127

Ostrowski, 1988, Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression, Mol. Carcinog., 1, 13, 10.1002/mc.2940010106

Patterson, 1997, Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9), J. Biol. Chem., 272, 28823, 10.1074/jbc.272.46.28823

Ritland, 1997, Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice, Cancer Res., 57, 3520

Rønnov-Jessen, 1996, Cellular changes involved in conversion of normal to malignant breast, Physiol. Rev., 76, 69, 10.1152/physrev.1996.76.1.69

Rudolph-Owen, 1998, The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis, Cancer Res., 58, 5500

Rutter, 1998, A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription, Cancer Res., 58, 5321

Sommers, 1994, Differentiation state and invasiveness of human breast cancer cell lines, Breast Cancer Res. Treat., 31, 325, 10.1007/BF00666165

Squartini, 1994, Tumours of the mammary gland

Sternlicht, 1999, ECM proteinases

Sun, 1998, Simultaneous loss of expression of syndecan-1 and E-cadherin in the embryonic palate during epithelial-mesenchymal transformation, Int. J. Dev. Biol., 42, 733

SundarRaj, 1992, Expression of vimentin by rabbit corneal epithelial cells during wound repair, Cell Tissue Res., 267, 347, 10.1007/BF00302973

Suzuki, 1997, Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site, J. Biol. Chem., 272, 31730, 10.1074/jbc.272.50.31730

Sympson, 1994, Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression, J. Cell Biol., 125, 681, 10.1083/jcb.125.3.681

Talhouk, 1992, Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution, J. Cell Biol., 118, 1271, 10.1083/jcb.118.5.1271

Tetsu, 1999, β-Catenin regulates expression of cyclin D1 in colon carcinoma cells, Nature, 398, 422, 10.1038/18884

Thomasset, 1998, Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development, Am. J. Pathol., 153, 457, 10.1016/S0002-9440(10)65589-7

Tlsty, 1998, Cell-adhesion-dependent influences on genomic instability and carcinogenesis, Curr. Opin. Cell Biol., 10, 647, 10.1016/S0955-0674(98)80041-0

Wargotz, 1989, Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma, Hum. Pathol., 20, 628, 10.1016/0046-8177(89)90149-4

Werb, 1997, ECM and cell surface proteolysis, Cell, 91, 439, 10.1016/S0092-8674(00)80429-8

Wilson, 1997, Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin, Proc. Natl. Acad. Sci. USA, 94, 1402, 10.1073/pnas.94.4.1402

Witty, 1995, Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development, Mol. Biol. Cell, 6, 1287, 10.1091/mbc.6.10.1287

Ye, 1996, Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression, J. Biol. Chem., 271, 13055, 10.1074/jbc.271.22.13055